Cash flow Statement (Quarterly, GAAP in millions $) |
(Mar 31 2025) 3 Months |
(Dec 31 2024) 12 Months |
(Sep 30 2024) 9 Months |
(Jun 30 2024) 6 Months |
(Mar 31 2024) 9 Months |
Income |
-3.93 |
-53.95 |
-44.89 |
-46.17 |
-17.99 |
Depreciation & amortization |
0.87 |
3.45 |
2.59 |
1.73 |
0.86 |
Amortization of Other Assets |
0.05 |
0.22 |
0.16 |
0.11 |
0.05 |
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense
|
- |
- |
- |
- |
- |
Restructuring & Impairment Charges |
- |
- |
- |
- |
- |
Provision for Doubtful Accounts |
- |
0.46 |
0.25 |
- |
- |
Increase (Decrease) in Inventories |
-0.38 |
-0.06 |
0.22 |
0.74 |
0.80 |
R & D, Environmental and Other Expense |
- |
- |
- |
- |
- |
Gain (Loss) on Disposition of Business |
- |
-0.18 |
-0.18 |
-0.18 |
- |
Share-based Compensation |
1.21 |
7.89 |
6.68 |
4.91 |
2.20 |
Income (Loss) from Equity Method Investments |
- |
- |
- |
- |
- |
Fair Value Adjustment of Warrants |
-5.19 |
14.88 |
15.32 |
27.97 |
9.64 |
Gain Loss On Revaluation Of Revenue Interest Obligation And Other |
- |
-1.44 |
-1.44 |
-1.44 |
- |
Interest Expense Recorded As Additional Revenue Interest Obligation |
0.70 |
2.09 |
1.45 |
0.78 |
2.47 |
Interest Expense Recorded As Convertible Preferred Stock |
- |
- |
- |
- |
- |
Increase Decrease In Obligations To Tissue Suppliers |
- |
- |
- |
- |
-1.05 |
Increase Decrease In Accounts Payable And Accrued Expenses And Payables To Tissue Suppliers |
- |
-0.98 |
-0.75 |
2.03 |
1.98 |
Increase Decrease Contingent Liability |
-2.62 |
9.27 |
5.17 |
0.57 |
- |
Losses On Product Recall And Market Withdrawal |
- |
- |
- |
0.18 |
- |
Income taxes |
- |
- |
- |
- |
- |
Losses/ -gains on Investments net |
- |
- |
- |
- |
- |
Accounts Receivable |
0.28 |
-1.54 |
-1.81 |
-1.98 |
-0.48 |
Increase (Decrease) in Accounts Payable and Accrued Liabilities |
-0.23 |
-1.15 |
- |
- |
- |
Accrued Expense |
- |
- |
- |
- |
- |
Deferred Revenue and Customer Advances and Deposits |
- |
- |
- |
- |
- |
Increase (Decrease) in Prepaid Expense and Other Assets |
0.45 |
0.74 |
2.17 |
1.35 |
0.17 |
Other Working Capital |
- |
- |
- |
- |
- |
Other Noncash Items |
- |
- |
- |
- |
- |
Other net |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Operating Activities |
-0.10 |
-0.47 |
0.15 |
0.13 |
0.00 |
Discontinued operations |
- |
- |
- |
- |
- |
Net Cash flow from
Operating Activities |
-8.88 |
-22.66 |
-10.40 |
-6.97 |
-2.64 |
Capital Expenditures |
-0.28 |
-0.65 |
-0.56 |
-0.01 |
-0.02 |
Sale of Capital Items |
- |
- |
- |
- |
- |
Short-term Investments Proceeds |
- |
- |
- |
- |
- |
Short-term Investments Acq. |
- |
- |
- |
- |
- |
Real Estate Investments |
- |
- |
- |
- |
- |
Restricted Cash and Investments Increase (Decrease) |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Loans |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Deposits |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Investments |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank |
- |
- |
- |
- |
- |
Acquisition Net of Cash Acquired |
- |
- |
- |
- |
- |
Interest in Subsidiaries and Affiliates |
- |
- |
- |
- |
- |
Proceeds from Divestiture of Businesses |
- |
0.18 |
0.18 |
0.18 |
- |
Accounts payable |
- |
- |
- |
- |
- |
Receivables |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Investing Activities |
- |
- |
- |
- |
- |
Other Net |
- |
0.00 |
0.00 |
0.00 |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Net Cash flow from Investing Activities |
-0.28 |
-0.47 |
-0.38 |
0.17 |
-0.02 |
Short-term debt Net |
- |
- |
- |
- |
- |
Other borrowing transactions |
- |
- |
- |
- |
- |
Long-term debt - borrowings |
- |
- |
- |
- |
- |
Long-term debt - repayments |
- |
-2.00 |
-2.00 |
-2.00 |
-2.00 |
Federal Home Loan Bank and Federal Funds |
- |
- |
- |
- |
- |
Issuances/ -repurchases
of Comm. Stock |
13.88 |
28.28 |
28.28 |
14.39 |
1.21 |
Partnership and Parent Transactions |
- |
- |
- |
- |
- |
Issuances/ -repurchases
of Pref. Stock |
- |
- |
- |
- |
- |
Deposits, Annuities, Contract Holders Funds |
- |
- |
- |
- |
- |
Other financing activities net |
- |
- |
- |
- |
- |
Other net |
-0.60 |
-1.78 |
-2.73 |
-1.47 |
-0.68 |
Payments On Revenue Interest Obligation |
- |
-6.30 |
-5.20 |
-2.60 |
- |
Proceeds From Transition Services Agreement Net |
- |
- |
- |
- |
- |
Payments Of Additional Stock Issuance Costs In Private Placement |
- |
- |
- |
- |
- |
Payments of Dividends, Preferred Stock and Preference Stock |
- |
- |
- |
- |
- |
Dividends paid |
- |
- |
- |
- |
- |
Net Cash flow from Financing Activities |
13.28 |
17.09 |
17.25 |
5.72 |
-4.07 |
Effect of exchange rate on cash flow |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Free
Cash Flow |
-9.16 |
-23.31 |
-10.96 |
-6.99 |
-2.66 |
Total Cash Flow |
4.12 |
-6.04 |
6.47 |
-1.09 |
-6.73 |